Europe Pharma Knowledge Management Software Market

ID: MRFR/ICT/61659-HCR
200 Pages
Aarti Dhapte
Last Updated: February 06, 2026
Europe Pharma Knowledge Management Software Market Research Report By Deployment (On-Premises, Cloud, Hybrid), By Organization Size (Small & Medium Enterprises, Large Enterprises) and By Regional (Germany, UK, France, Russia, Italy, Spain, Rest of Europe)- Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Information and Communications Technology, BY Application (USD Million)
      1. 4.1.1 Clinical Data Management
      2. 4.1.2 Regulatory Compliance
      3. 4.1.3 Knowledge Sharing
      4. 4.1.4 Research and Development
      5. 4.1.5 Training and Education
    2. 4.2 Information and Communications Technology, BY End Use (USD Million)
      1. 4.2.1 Pharmaceutical Companies
      2. 4.2.2 Biotechnology Firms
      3. 4.2.3 Contract Research Organizations
      4. 4.2.4 Academic Institutions
    3. 4.3 Information and Communications Technology, BY Deployment Type (USD Million)
      1. 4.3.1 Cloud-Based
      2. 4.3.2 On-Premises
      3. 4.3.3 Hybrid
    4. 4.4 Information and Communications Technology, BY User Type (USD Million)
      1. 4.4.1 Researchers
      2. 4.4.2 Regulatory Affairs Professionals
      3. 4.4.3 IT Administrators
      4. 4.4.4 Clinical Staff
    5. 4.5 Information and Communications Technology, BY Functionality (USD Million)
      1. 4.5.1 Document Management
      2. 4.5.2 Collaboration Tools
      3. 4.5.3 Data Analytics
      4. 4.5.4 Workflow Automation
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Information and Communications Technology
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Information and Communications Technology
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 SAP (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Oracle (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 IBM (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Microsoft (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Veeva Systems (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Qualio (IE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Medidata Solutions (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 PharmaLex (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Cegedim (FR)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 EUROPE MARKET ANALYSIS BY APPLICATION
    3. 6.3 EUROPE MARKET ANALYSIS BY END USE
    4. 6.4 EUROPE MARKET ANALYSIS BY DEPLOYMENT TYPE
    5. 6.5 EUROPE MARKET ANALYSIS BY USER TYPE
    6. 6.6 EUROPE MARKET ANALYSIS BY FUNCTIONALITY
    7. 6.7 KEY BUYING CRITERIA OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
    10. 6.10 DRIVERS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
    12. 6.12 SUPPLY / VALUE CHAIN: INFORMATION AND COMMUNICATIONS TECHNOLOGY
    13. 6.13 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USE, 2024 (% SHARE)
    16. 6.16 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USE, 2024 TO 2035 (USD Million)
    17. 6.17 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DEPLOYMENT TYPE, 2024 (% SHARE)
    18. 6.18 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DEPLOYMENT TYPE, 2024 TO 2035 (USD Million)
    19. 6.19 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY USER TYPE, 2024 (% SHARE)
    20. 6.20 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY USER TYPE, 2024 TO 2035 (USD Million)
    21. 6.21 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY FUNCTIONALITY, 2024 (% SHARE)
    22. 6.22 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY FUNCTIONALITY, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY END USE, 2026-2035 (USD Million)
      3. 7.2.3 BY DEPLOYMENT TYPE, 2026-2035 (USD Million)
      4. 7.2.4 BY USER TYPE, 2026-2035 (USD Million)
      5. 7.2.5 BY FUNCTIONALITY, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Europe Europe Pharma Knowledge Management Software Market Segmentation

Europe Pharma Knowledge Management Software Market By Application (USD Million, 2022-2035)

  • Clinical Data Management
  • Regulatory Compliance
  • Knowledge Sharing
  • Research and Development
  • Training and Education

Europe Pharma Knowledge Management Software Market By End Use (USD Million, 2022-2035)

  • Pharmaceutical Companies
  • Biotechnology Firms
  • Contract Research Organizations
  • Academic Institutions

Europe Pharma Knowledge Management Software Market By Deployment Type (USD Million, 2022-2035)

  • Cloud-Based
  • On-Premises
  • Hybrid

Europe Pharma Knowledge Management Software Market By User Type (USD Million, 2022-2035)

  • Researchers
  • Regulatory Affairs Professionals
  • IT Administrators
  • Clinical Staff

Europe Pharma Knowledge Management Software Market By Functionality (USD Million, 2022-2035)

  • Document Management
  • Collaboration Tools
  • Data Analytics
  • Workflow Automation

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035